Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 158


Production of a Double-Layer Scaffold for the "On-Demand" Release of Fibroblast-like Limbal Stem Cells.

Fiorica C, Tomasello L, Palumbo FS, Coppola A, Pitarresi G, Pizzolanti G, Giordano C, Giammona G.

ACS Appl Mater Interfaces. 2019 Jun 12. doi: 10.1021/acsami.9b06757. [Epub ahead of print]


Knockdown of NANOG Reduces Cell Proliferation and Induces G0/G1 Cell Cycle Arrest in Human Adipose Stem Cells.

Pitrone M, Pizzolanti G, Coppola A, Tomasello L, Martorana S, Pantuso G, Giordano C.

Int J Mol Sci. 2019 May 26;20(10). pii: E2580. doi: 10.3390/ijms20102580.


Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study.

Fadini GP, Sciannameo V, Franzetti I, Bottigliengo D, D'Angelo P, Vinci C, Berchialla P, Arena S, Buzzetti R, Avogaro A; DARWIN-T2D network.

Diabetes Obes Metab. 2019 Apr 15. doi: 10.1111/dom.13747. [Epub ahead of print]


The medical treatment with pasireotide in Cushing's disease: an Italian multicentre experience based on "real-world evidence".

Pivonello R, Arnaldi G, Scaroni C, Giordano C, Cannavò S, Iacuaniello D, Trementino L, Zilio M, Guarnotta V, Albani A, Cozzolino A, Michetti G, Boscaro M, Colao A.

Endocrine. 2019 Jun;64(3):657-672. doi: 10.1007/s12020-018-1818-7. Epub 2019 Apr 9.


Novel compound mutations in the mitochondrial translation elongation factor (TSFM) gene cause severe cardiomyopathy with myocardial fibro-adipose replacement.

Perli E, Pisano A, Glasgow RIC, Carbo M, Hardy SA, Falkous G, He L, Cerbelli B, Pignataro MG, Zacara E, Re F, Della Monica PL, Morea V, Bonnen PE, Taylor RW, d'Amati G, Giordano C.

Sci Rep. 2019 Mar 25;9(1):5108. doi: 10.1038/s41598-019-41483-9.


Neuromuscular magnetic stimulation counteracts muscle decline in ALS patients: results of a randomized, double-blind, controlled study.

Musarò A, Dobrowolny G, Cambieri C, Onesti E, Ceccanti M, Frasca V, Pisano A, Cerbelli B, Lepore E, Ruffolo G, Cifelli P, Roseti C, Giordano C, Gori MC, Palma E, Inghilleri M.

Sci Rep. 2019 Feb 26;9(1):2837. doi: 10.1038/s41598-019-39313-z.


Hepatic Steatosis Index in Acromegaly: Correlation with Insulin Resistance Regardless of the Disease Control.

Ciresi A, Guarnotta V, Campo D, Giordano C.

Int J Endocrinol. 2018 Dec 19;2018:5421961. doi: 10.1155/2018/5421961. eCollection 2018.


Circulating Irisin Levels in Children With GH Deficiency Before and After 1 Year of GH Treatment.

Ciresi A, Pizzolanti G, Guarnotta V, Giordano C.

J Clin Endocrinol Metab. 2019 Mar 1;104(3):801-808. doi: 10.1210/jc.2018-01440.


Impact of a Mediterranean Dietary Pattern and Its Components on Cardiovascular Risk Factors, Glucose Control, and Body Weight in People with Type 2 Diabetes: A Real-Life Study.

Vitale M, Masulli M, Calabrese I, Rivellese AA, Bonora E, Signorini S, Perriello G, Squatrito S, Buzzetti R, Sartore G, Babini AC, Gregori G, Giordano C, Clemente G, Grioni S, Dolce P, Riccardi G, Vaccaro O; TOSCA.IT Study Group.

Nutrients. 2018 Aug 10;10(8). pii: E1067. doi: 10.3390/nu10081067.


Improved Cardiovascular and Cardiometabolic Risk in Patients With Type 1 Diabetes and Autoimmune Polyglandular Syndrome Switched From Glargine to Degludec Due to Hypoglycaemic Variability.

Guarnotta V, Di Bella G, Pillitteri G, Ciresi A, Giordano C.

Front Endocrinol (Lausanne). 2018 Jul 26;9:428. doi: 10.3389/fendo.2018.00428. eCollection 2018.


Phenotyping normal kidney function in elderly patients with type 2 diabetes: a cross-sectional multicentre study.

Fadini GP, Solini A, Manca ML, Zatti G, Karamouzis I, Di Benedetto A, Frittitta L, Avogaro A; DARWIN-T2D Network.

Acta Diabetol. 2018 Nov;55(11):1121-1129. doi: 10.1007/s00592-018-1194-z. Epub 2018 Aug 9.


Growth hormone and hematopoiesis: A retrospective analysis on a large cohort of children with growth hormone deficiency.

Ciresi A, Piazza G, Radellini S, Guarnotta V, Mineo MG, Giordano C.

Growth Horm IGF Res. 2018 Oct - Dec;42-43:8-13. doi: 10.1016/j.ghir.2018.07.005. Epub 2018 Jul 20.


Diabetes Secondary to Acromegaly: Physiopathology, Clinical Features and Effects of Treatment.

Ferraù F, Albani A, Ciresi A, Giordano C, Cannavò S.

Front Endocrinol (Lausanne). 2018 Jul 6;9:358. doi: 10.3389/fendo.2018.00358. eCollection 2018. Review.


Effects of pasireotide treatment on coagulative profile: a prospective study in patients with Cushing's disease.

Barbot M, Guarnotta V, Zilio M, Ceccato F, Ciresi A, Daniele A, Pizzolanti G, Campello E, Frigo AC, Giordano C, Scaroni C.

Endocrine. 2018 Oct;62(1):207-214. doi: 10.1007/s12020-018-1669-2. Epub 2018 Jul 6.


Glucose Metabolism in Children With Growth Hormone Deficiency.

Ciresi A, Giordano C.

Front Endocrinol (Lausanne). 2018 Jun 11;9:321. doi: 10.3389/fendo.2018.00321. eCollection 2018. Review.


The metabolic outcomes of growth hormone treatment in children are gender specific.

Ciresi A, Radellini S, Guarnotta V, Mineo MG, Giordano C.

Endocr Connect. 2018 Jul;7(7):879-887. doi: 10.1530/EC-18-0135. Epub 2018 Jun 20.


Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study.

Fadini GP, Bottigliengo D, D'Angelo F, Cavalot F, Bossi AC, Zatti G, Baldi I, Avogaro A; DARWIN-T2D Network.

Diabetes Ther. 2018 Aug;9(4):1477-1490. doi: 10.1007/s13300-018-0452-y. Epub 2018 Jun 1.


Coronary atherosclerosis and sudden cardiac death in the young: another face of the culprit, another way of striking?

d'Amati G, Cerbelli B, Giordano C.

Int J Cardiol. 2018 Aug 1;264:28-29. doi: 10.1016/j.ijcard.2018.03.122. No abstract available.


Higher cardiometabolic risk in idiopathic versus autoimmune type 1 diabetes: a retrospective analysis.

Guarnotta V, Vigneri E, Pillitteri G, Ciresi A, Pizzolanti G, Giordano C.

Diabetol Metab Syndr. 2018 May 10;10:40. doi: 10.1186/s13098-018-0341-6. eCollection 2018.


Supplemental Content

Loading ...
Support Center